TP53 and cervical carcinoma: Fisher's exact test showed marginal statistical significance (<i>p</i> = 0.059).<h4>Conclusion</h4>The findings underscore the relevance of TP53 screening in populations at risk of cervical cancer, while BRCA2 screening may be less applicable in this cohort.